Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Kingdom of Saudi Arabia Ministry of Health King Fahad Medical City اﻟﻤﻤﻠﻜﺔ اﻟﻌﺮب اﻟﺴﻌﻮدﯾﺔ وزاره اﻟﺼﺤﺔ ﻣﺪﯾﻨﮫ اﻟﻤﻠﻚ ﻓﮭﺪ اﻟﻄﺒﯿﺔ Nuclear Medicine Section Medical Imaging Administration Tel No.: 288 9999 ext 1047/1048 Fax No.: 288 9999 ext 1046 Leaflet E: INSTRUCTIONS TO EMU NURSING STAFF ON SEIZURE (ICTAL & POST ICTAL) BRAIN PERFUSION SPECT STUDY - Study is scheduled by the neurologist of EMU in conjunction with supervising nuclear medicine (NM) physician and coordinated through both Nuclear Medicine Section and the Epilepsy Monitoring Unit (EMU). - Female patients should not be pregnant. If the patient is breast-feeding, the patient should stop breast-feeding for 24 hr after injection of radiopharmaceutical and discard the milk. - A list of patient's present medications, neurological & neuropsychiatry history, and CT and MRI scans findings, renal function, allergy to food, dyes & preservatives should be made available to the NM physicians before the study is scheduled. Need to determine if any of patient's medications should be withheld for the test. - Patient is admitted in EMU for seizures monitoring. Caffeine products like tea, coffee and colas, alcohol and other drugs such as benzodiazepines that may affect brain flow should be withheld for 24 hrs before the test. Otherwise, patient may eat and drink as usual. The patient should be well hydrated. - Cerebral Perfusion SPECT study will be done between 8.30 am and 3 pm. - NM technologist has to identify the patient. Verify NM physician's order. Explain the procedure to patient and relatives, and to nursing staff. Explain and instruct patient to remain motionless during imaging. It is critical that the patient be able to lie still for the duration of the scan. Excessive motion and improper positioning can render an examination uninterruptible. If the patient is agitated or confused, having a family member present may be helpful If this may be a problem, the NM physician should be informed so that modifications to scan acquisition may be contemplated, such as doing a series of shorter scans, rather than a long one. All these should be preferably done before injection of radiopharmaceutical. - An i.v catheter line is inserted in the patient's hand or arm and flushed with heparinised saline in advance by EMU nurse, so that the patient does not experience pain from the needle puncture at the time of radiopharmaceutical injection ( as it can influence cerebral blood flow ). - Patient is monitored in a quiet room with subdued dim lighting. Little soft or no speaking, no noise from within or outside, or interacting with staff from 15 min before to 15 min after injection of radiopharmaceutical is necessary. This is to limit extraneous brain activity that could influence brain flow. No sitters or roommates should be present until the injection is complete. 1 - Patient should not be sedated prior to injection of radiopharmaceutical unless necessary. Sedation, if necessary to facilitate SPECT imaging, should only be given 15 after radiopharmaceutical administration. - NM technologist takes to the EMU an adult dose 30 mCi of Tc-99m-ECD (neurolite)in a syringe with leaded syringe shield, labeled as to content (30), in a lead box carrying case and places it in a secured area. The activity remaining in the syringe at 1, 2, 3, 4, 5, 6 hr should be provided and explained to the EMU nurses. Dose for children is adjusted according to weight. If the patient is not injected, the syringe dose must be topped up by the NM technologist to a full dose of 30 mCi (1110 MBq) or to a dose appropriate for a child, every 2-3hrs. If the dose is not used within 6 hrs of reconstitution it shall be considered expired and discarded as radioactive waste by the NM technologist.Tc-99m-ECD is stable up to 6 hr post reconstitution. - When the EMU nurse notes the onset of seizure activity, the full dose of Tc-99m-ECD is to be immediately injected intravenously through existing i.v line as a slow bolus push followed with a 10 ml heparinised saline flush. This injection is to be performed only by an EMU nurse trained to give Tc-99m-ECD injection and in radiation protection. Gloves must be worn. The empty syringe should be placed back into the leaded carrying box, and disposed by NM technologist. - The EMU nurse injecting the patient will record the exact time of injection. Time should be recorded in terms of both the clock time as well as the time in seconds between onset of seizure activity and the bolus injection. This time in seconds should be as accurate as possible and can be obtained by review of the video record. - The patient should be well hydrated and encouraged to drink plenty of fluids (adults 500 ml of water taken after injection of Tc99m-ECD) and void frequently with 2 hours interval for at least 6 hours post-injection. This will decrease radiation exposure to the bladder wall. - Once the patient is stable, the EMU staff will contact NM unit and arrange a time for the image acquisition. The NM reception staff should give a time earliest as possible. The image acquisition should begin within 2 hrs of injection. EEG leads should be removed in the EMU, empty bowel and bladder, change diapers (if applicable) and paediatric urine collector inserted for child who has no bladder control, before sending the patient down to NM for imaging. - The neurologist prescribes sedation with intravenous Lorazepam or equivalent, if necessary to facilitate SPECT imaging. It should be given only 15 min after injection of Tc-99m-ECD via existing intravenous line by EMU nurse in the imaging room and not in the EMU (as the patient needs to be moved to the imaging table). - An EMU nurse will accompany the patient to NM unit and return the patient to the EMU afterwards. - If the patient had no baseline Interictal study, this should be booked in conjunction with the EMU neurologist and the supervising NM physician. 2